Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Total Debt: 2014-2025

Historic Total Debt for BIO-TECHNE (TECH) over the last 12 years, with Jun 2025 value amounting to $346.0 million.

  • BIO-TECHNE's Total Debt changed negligibly% to $300.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $300.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $346.0 million for FY2025, which is 8.46% up from last year.
  • As of FY2025, BIO-TECHNE's Total Debt stood at $346.0 million, which was up 8.46% from $319.0 million recorded in FY2024.
  • Over the past 5 years, BIO-TECHNE's Total Debt peaked at $353.5 million during FY2023, and registered a low of $255.9 million during FY2022.
  • Its 3-year average for Total Debt is $339.5 million, with a median of $346.0 million in 2025.
  • Its Total Debt has fluctuated over the past 5 years, first dropped by 25.02% in 2022, then skyrocketed by 38.13% in 2023.
  • Over the past 5 years, BIO-TECHNE's Total Debt (Yearly) stood at $341.3 million in 2021, then fell by 25.02% to $255.9 million in 2022, then surged by 38.13% to $353.5 million in 2023, then declined by 9.76% to $319.0 million in 2024, then increased by 8.46% to $346.0 million in 2025.